US Bancorp’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,474
Closed -$4.48K 4390
2024
Q4
$4.48K Sell
1,474
-471
-24% -$1.43K ﹤0.01% 3670
2024
Q3
$10.1K Buy
1,945
+175
+10% +$908 ﹤0.01% 3356
2024
Q2
$4.55K Sell
1,770
-1,232
-41% -$3.17K ﹤0.01% 3533
2024
Q1
$14.8K Buy
3,002
+573
+24% +$2.82K ﹤0.01% 3195
2023
Q4
$21.4K Sell
2,429
-846
-26% -$7.44K ﹤0.01% 3018
2023
Q3
$37.6K Buy
3,275
+60
+2% +$688 ﹤0.01% 2578
2023
Q2
$81.4K Sell
3,215
-763
-19% -$19.3K ﹤0.01% 2268
2023
Q1
$128K Sell
3,978
-22,403
-85% -$722K ﹤0.01% 2074
2022
Q4
$487K Buy
26,381
+9,382
+55% +$173K ﹤0.01% 1411
2022
Q3
$458K Buy
16,999
+16,147
+1,895% +$435K ﹤0.01% 1429
2022
Q2
$12K Sell
852
-1,254
-60% -$17.7K ﹤0.01% 3305
2022
Q1
$41K Sell
2,106
-425
-17% -$8.27K ﹤0.01% 2719
2021
Q4
$41K Buy
2,531
+2,256
+820% +$36.5K ﹤0.01% 2744
2021
Q3
$8K Hold
275
﹤0.01% 3507
2021
Q2
$8K Hold
275
﹤0.01% 3481
2021
Q1
$8K Buy
275
+18
+7% +$524 ﹤0.01% 3364
2020
Q4
$7K Hold
257
﹤0.01% 3296
2020
Q3
$6K Hold
257
﹤0.01% 3203
2020
Q2
$6K Buy
257
+59
+30% +$1.38K ﹤0.01% 3204
2020
Q1
$3K Hold
198
﹤0.01% 3333
2019
Q4
$3K Sell
198
-545
-73% -$8.26K ﹤0.01% 3369
2019
Q3
$10K Buy
743
+198
+36% +$2.67K ﹤0.01% 3061
2019
Q2
$7K Sell
545
-128
-19% -$1.64K ﹤0.01% 3212
2019
Q1
$11K Buy
673
+173
+35% +$2.83K ﹤0.01% 3041
2018
Q4
$10K Sell
500
-260
-34% -$5.2K ﹤0.01% 3043
2018
Q3
$19K Hold
760
﹤0.01% 2946
2018
Q2
$21K Buy
760
+260
+52% +$7.18K ﹤0.01% 2924
2018
Q1
$15K Buy
+500
New +$15K ﹤0.01% 3042